Silence Therapeutics plc (SLN) Financials

SLN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 106.4 million 67.9 million
March 31, 2026 115.1 million 65.7 million
Dec. 31, 2025 131.4 million 69.1 million
Sept. 30, 2025 146.8 million 72.7 million

SLN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 1.5 million 1.3 million
March 31, 2026 -15.6 million 2.4 million
Dec. 31, 2025 -17.3 million 7.3 million
Sept. 30, 2025 -10.9 million 2.5 million

SLN Net Income

No data available :(

SLN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 72.1 million -9000 -
March 31, 2026 70.1 million - 135999
Dec. 31, 2025 85.1 million - 160000
Sept. 30, 2025 102.2 million - 182000

SLN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 47.2 million
March 31, 2026 47.2 million
Dec. 31, 2025 47.2 million
Sept. 30, 2025 15.7 million

SLN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 3 8.3 million 4.7 million -
March 31, 2026 - 8.3 million 7.0 million -
Dec. 31, 2025 55000 8.7 million 3.7 million -
Sept. 30, 2025 3000 20.5 million 5.8 million -

SLN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 108195
March 31, 2026 421292 116803
Dec. 31, 2025 34000 12000
Sept. 30, 2025 159000 64000

SLN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

SLN

Price: $13.72

52 week price:
4.19
17.58

Earnings Per Share: -1.19 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United Kingdom

Volume: 18800

Market Capitalization: 641.4 million

Links: